The past year has seen a global business community in the midst of foundational change. While record-breaking M&A and fast-paced digital transformation have presented big opportunities and unique challenges across every sector, the emergence of COVID-19 has been a forcing function for the life sciences industry to innovate, fast.
From AI to blockchain, emerging technologies that you may associate with fast-paced tech companies are now disrupting how pharmaceutical firms function. During this webcast, former Head of Competitive Intelligence at Roche and Novartis, Salvador Carlucci, discusses how these and other innovative tools have the power to transform the world (and already have).
What he discusses:
- The rise of exponential technologies in pharma
- The potential of these new technologies to save billions in developmental costs, reduce the development roadmap and even revamp market approach
- How Moderna leveraged emerging tech to beat Big Pharma in the race to fight COVID-19
- What to expect from pharma companies in the race to compete for more market share